BAFFI ROBERT 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 4, 2020
Insider Transaction Report
Form 4
BAFFI ROBERT
SVP, Technial Operations
Transactions
- Award
Common Stock
2020-03-03+9,852→ 117,579 total
Holdings
- 71,882(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.
- [F2]Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements.
- [F3]Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.